A REVIEW ARTICLE ON NOVEL DRUG'S TARGETING PARKINSONS DISEASE

Parkinson’s Disease is a common neurodegenerative disease characterised by rigidity, rest tremor, postural instability. The main aim of this article is to provide knowledge about the novel drugs that are being used in the treatment of Parkinson disease which are currently investigated and study the possibility in therapeutic targets. The novel therapeutic approach is to ensure the symptological control in the Parkinson disease patient. The treatment options are limited with most of the current novel therapeutic approach based on restoration of the dopaminergic tone in the Striatum. As we understand the pathogenesis of PD Accomplished the novel therapeutic drugs are emerged to control the symptoms of PD without problematic side effects. This novel approach ensures the expedited route to the clinics by providing the safety data regarding the novel therapeutic approach in managing the PD patients. These novel therapeutic approaches targeting on PD treatment are likely to evolve considerably over the next coming years.

Keyword : Novel Dopaminergic Drugs, Deep Brain Stimulation, Stem cell Therapy, Exabalate Neuro System, Novel Levodopa formulation.